Nirav Mehta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Morgan Stanley, India Life Sciences funds acquire control of Maiva Pharma, invest Rs 1,000 crore

The company plans to use the proceeds of the investment to set up a new manufacturing facility near Hosur.

Tamil naduSumit guptaMaiva pharmaBhaskar krishnaNirav mehtaIndia life sciencesBrazilian health regulatory agencyIndia life sciences fundMorgan stanleyMorgan stanley private equity asiaBengaluru based maivaMorgan stanley private equityPrivate equityOrgan stanley pe asiaIndia life sciences fund

Maiva Pharma: Maiva Pharma raises Rs 1000 crore from Morgan Stanley Private Equity, InvAscent

Morgan Stanley PE Asia and India Life Sciences Fund are investing almost equally, total stake with both funds combined will be over 60% post primary investment, the company told ET.

Tamil naduNirav mehtaSumit guptaMaiva pharmaBhaskar krishnaIndia life sciences fundContract developmentManufacturing organizationMorgan stanley private equity asiaMorgan stanley private equityInvestment managerPrivate equityMorgan stanleyUs market

Injectables maker Maiva Pharma raises ₹1,000 crore to set up new manufacturing unit

The company has a portfolio of over 75 products in CDMO services across the US, Canada, Europe, Australia, and LATAM markets.

Tamil naduUnited statesMaiva pharmaBhaskar krishnaNirav mehtaAdvent internationalContract developmentManufacturing organizationLatin americanApollo hospitalStanley private equity asiaMorgan stanley private equityIvycap venturesMorgan stanley private equity asia

Injectables company Maiva Pharma raises ₹1,000 crore - The Hindu BusinessLine

Injectables company Maiva Pharma raises ₹1,000 crore - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Tamil naduUnited statesBhaskar krishnaNirav mehtaMaiva pharmaManufacturing organizationIndia life sciences fundContract developmentMorgan stanley private equity asiaMaiva managing directorManaging director

Morgan Stanley: Maiva Pharma raises Rs 1,000 cr from Morgan Stanley PE and India Life Sciences Fund

Maiva Pharma has raised Rs 1,000 crore from Morgan Stanley Private Equity Asia and India Life Sciences Fund, including both primary and secondary funding. The funds will be used to set up a new manufacturing facility near Karnataka s Hosur, with capabilities in sterile dosage forms, including pre-filled syringes, bags, oncology, and hormonal injectables. Maiva s complex injectables development and manufacturing capability, strong compliance and regulatory standards, and transparency differentiate the company from competitors.

Karnataka hosurSumit guptaBhaskar krishnaNirav mehtaIndia life sciences fundMaiva pharmaMorgan stanley private equity asiaIndia life sciencesManaging directorChief executive bhaskar krishnaCo head nirav mehtaMorgan stanleyPrivate equityManufacturing facility